A double dose of vaccine news have helped to boost US stocks [Video]
![A double dose of vaccine news have helped to boost US stocks [Video]](https://editorial.fxstreet.com/images/Markets/Equities/SP500/wall_street_nyse3-637299021683820849_XtraLarge.jpg)
Listen to the latest market mood for the S&P500.
The risk tone has been broadly higher over the last week in the markets as a double dose of vaccine news boosted risk sentiment, and US stocks, higher. The Pfizer/BioNtech vaccine news last week and the Moderna vaccine news yesterday have all helped to boost US stocks.
Although wider questions do remain in the near term about how COVID-19 cases will drag on economies short term, the bigger picture is positive for stocks deep into 2021. On top of this seasonally the S&P500 does very will at the end of November in the run up to early December. In the last 10 years the S&P500 has only lost twice between 22 Nov and 2 December.
Therefore, expect S&P500 buyers on pullbacks.
Trade Risks: The main risk to this trade is if there is a negative change in the risk tone and/or the US has a national lockdown.
Author

Giles Coghlan LLB, Lth, MA
Financial Source
Giles is the chief market analyst for Financial Source. His goal is to help you find simple, high-conviction fundamental trade opportunities. He has regular media presentations being featured in National and International Press.


















